RLS Global logo
RLS logo

RLS GlobalOM:RLS Stock Report

Market Cap SEK 35.6m
Share Price
n/a
1Y-84.2%
7D-0.2%
Portfolio Value
View

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

RLS Stock Overview

RLS Global AB (publ), a medical technology company, develops and sells products for minimally invasive treatment in Sweden. More details

RLS fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

RLS Global AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for RLS Global
Historical stock prices
Current Share PriceSEK 0.45
52 Week HighSEK 3.49
52 Week LowSEK 0.21
Beta0.57
1 Month Change-26.16%
3 Month Change-35.36%
1 Year Change-84.18%
3 Year Change-93.07%
5 Year Change-93.59%
Change since IPO-70.27%

Recent News & Updates

Recent updates

We're Not Very Worried About RLS Global's (STO:RLS) Cash Burn Rate

Jan 13
We're Not Very Worried About RLS Global's (STO:RLS) Cash Burn Rate

Shareholder Returns

RLSSE PharmaceuticalsSE Market
7D-0.2%3.1%2.6%
1Y-84.2%15.5%14.3%

Return vs Industry: RLS underperformed the Swedish Pharmaceuticals industry which returned 28.5% over the past year.

Return vs Market: RLS underperformed the Swedish Market which returned 5.8% over the past year.

Price Volatility

Is RLS's price volatile compared to industry and market?
RLS volatility
RLS Average Weekly Movement18.5%
Pharmaceuticals Industry Average Movement9.0%
Market Average Movement5.6%
10% most volatile stocks in SE Market12.0%
10% least volatile stocks in SE Market3.2%

Stable Share Price: RLS's share price has been volatile over the past 3 months.

Volatility Over Time: RLS's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
19969Roland Frosingrls.global

RLS Global AB (publ), a medical technology company, develops and sells products for minimally invasive treatment in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. RLS Global AB (publ), was founded in 1996 and is based in Mölndal, Sweden.

RLS Global AB (publ) Fundamentals Summary

How do RLS Global's earnings and revenue compare to its market cap?
RLS fundamental statistics
Market capSEK 35.62m
Earnings (TTM)-SEK 28.81m
Revenue (TTM)SEK 1.08m

33.1x

P/S Ratio

-1.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RLS income statement (TTM)
RevenueSEK 1.08m
Cost of RevenueSEK 5.10m
Gross Profit-SEK 4.02m
Other ExpensesSEK 24.78m
Earnings-SEK 28.81m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Nov 23, 2023

Earnings per share (EPS)-0.36
Gross Margin-374.07%
Net Profit Margin-2,677.32%
Debt/Equity Ratio0%

How did RLS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/11/22 17:51
End of Day Share Price 2023/11/17 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

RLS Global AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Erik NordströmRedeye
Gustaf MeyerRedeye